FDA Inspection
Aventis Pharma Manufacturing Pte. Ltd.Aventis Pharma Manufacturing Pte. Ltd. – FDA Inspection, Oct 13, 2017
Record Details
This FDA Inspection record concerns Aventis Pharma Manufacturing Pte. Ltd., with an inspection on October 13, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 808e1341-af4e-42e2-ba43-6014e4f202f5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1032305
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Aventis Pharma Manufacturing Pte. Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 13, 2025 | Not classified | Office of Inspections and Investigations | |
| November 1, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 22, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 9, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aventis Pharma Manufacturing Pte. Ltd.
- FDA Inspection 1274305 - 2025-06-13
- FDA Inspection 1113084 - 2019-11-01
- FDA Inspection 933845 - 2015-05-22
- FDA Inspection 773423 - 2012-03-09
- FDA Inspection 677605 - 2010-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.